BRCA2 antagonizes classical and alternative nonhomologous end-joining to prevent gross genomic instability.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29133916.
- Also identified by DOI 10.1038/s41467-017-01759-y and PMC identifier 5684403.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
BRCA2-deficient cells exhibit gross genomic instability, but the underlying mechanisms are not fully understood. Here we report that inactivation of BRCA2 but not RAD51 destabilizes RPA-coated single-stranded DNA (ssDNA) structures at resected DNA double-strand breaks (DSBs) and greatly enhances the frequency of nuclear fragmentation following cell exposure to DNA damage. Importantly, these BRCA2-associated deficits are fueled by the aberrant activation of classical (c)- and alternative (alt)- nonhomologous end-joining (NHEJ), and rely on the well-defined DNA damage signaling pathway involving the pro-c-NHEJ factor 53BP1 and its downstream effector RIF1. We further show that the 53BP1-RIF1 axis promotes toxic end-joining events via the retention of Artemis at DNA damage sites. Accordingly, loss of 53BP1, RIF1, or Artemis prolongs the stability of RPA-coated DSB intermediates in BRCA2-deficient cells and restores nuclear integrity. We propose that BRCA2 antagonizes 53BP1, RIF1, and Artemis-dependent c-NHEJ and alt-NHEJ to prevent gross genomic instability in a RAD51-independent manner.
Medical subject headings
- BRCA2 Protein
- DNA Breaks, Double-Stranded
- DNA End-Joining Repair
- Endonucleases
- Genomic Instability
- Nuclear Proteins
- Telomere-Binding Proteins
- Tumor Suppressor p53-Binding Protein 1